DAWN SG&A Expense Growth
Day One Biopharmaceuticals Inc · SG&A Expense Growth
DAWN SG&A Expense Growth
Latest reported4.45%period ending
DAWN FY SG&A Growth (YoY) (0.00% → 4.45%)
Latest values, visible window
High-resolution chart · PNG
DAWN sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 4.4495% | |
| 52.8269% | |
| 23.253% | |
| 110.1958% | |
| 522.7894% | |
| 365.4076% | |
| 0% |